NCT01752881View on ClinicalTrials.gov

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza vaccine (split virion, inactivated)

"AdimFlu-S, Inactivated Influenza Vaccine Trivalent Types A and B (Split) Formulation 2012-2013~Dosage: 0.5mL/per syringe~Administration route: Intramuscular Injection, once"

BIOLOGICAL

AdimFlu-S

Trial Locations (1)

Unknown

National Cheng Kung University Hospital, Tainan City

Sponsors
All Listed Sponsors
lead

Adimmune Corporation

INDUSTRY